Today: 21 May 2026
Tesla stock slips as Musk pulls $8,000 Full Self-Driving option, goes subscription-only
14 January 2026
1 min read

Tesla stock slips as Musk pulls $8,000 Full Self-Driving option, goes subscription-only

New York, January 14, 2026, 09:39 ET — Regular session

  • Tesla shares dipped roughly 0.4% early, following Musk’s announcement that FSD will move to a subscription-only model starting Feb. 14
  • Move eliminates the one-time purchase option for the driver-assistance package
  • Investors are eyeing the Jan. 28 earnings report for updates on software revenue and regulatory scrutiny

Tesla shares dipped about 0.4% to $447.20 in early Wednesday trading, after closing at $449.04 Tuesday. CEO Elon Musk announced the company will stop selling its Full Self-Driving software outright, switching to a monthly subscription model starting Feb. 14. The driver-assistance package, now called “FSD (Supervised),” currently costs U.S. buyers $8,000 upfront or $99 per month. U.S. safety regulators launched an investigation last year into 2.88 million Teslas with the system, following over 50 reports of crashes and traffic-safety issues. Reuters

Tesla’s pricing adjustment goes beyond a simple checkout tweak. It pushes the autonomy narrative closer to recurring revenue — the kind investors crave for steadier, higher-margin growth.

Tesla is set to release its fourth-quarter earnings on Jan. 28. Investors will get an early read on software revenue and hear how the company plans to address regulatory concerns tied to its driver-assistance tech.

Priced at $99 a month, it would take about seven years of payments to equal the previous $8,000 upfront cost. This makes it more affordable initially, but you lose the chance to pay once and own it outright.

Wolfe Research’s Emmanuel Rosner described himself as “tactically constructive” on Tesla, despite highlighting a challenging near-term environment. He also emphasized autonomy as a crucial factor in the stock’s long-term outlook. Barron’s

On Wednesday, Tesla agreed to mediation with the U.S. Equal Employment Opportunity Commission over allegations of widespread harassment of Black workers at its Fremont, California plant. The EEOC indicated that talks might start in March or April. Meanwhile, the judge has put some evidence deadlines on hold to focus on the mediation process.

A regulatory filing revealed that senior vice president Xiaotong Zhu was granted stock options linked to 520,021 shares, priced at $435.80 each, with vesting starting in 2027.

Driver-assistance subscriptions are heating up as automakers race to monetize software features with steady revenue streams. Tesla faces a tricky spot: the feature requires drivers to stay alert, despite the company’s heavy push on autonomous branding.

The downside is clear. Safety probes could drag out, leading to updates and stiffening public and regulatory skepticism. Stronger moves from regulators might dent adoption and drive up costs.

Tesla’s stock now moves just as much on autonomy news as on car sales and profit margins. This dynamic can cut both ways, particularly when investors crunch the numbers on potential recurring software revenue—and the timeline to reach it.

Tesla’s next major event hits Jan. 28, with earnings and a Q&A focused on its software plans. The move to subscription-only for FSD kicks in Feb. 14.

Stock Market Today

  • Clarity Pharmaceuticals Shares Surge 9.33% on ASX Amid Biotech Sector Rally
    May 21, 2026, 10:09 AM EDT. Clarity Pharmaceuticals Ltd (ASX: CU6) shares jumped 9.33% to A$2.76 on May 21, 2026, driven by renewed investor interest in Australian biotech stocks. The stock's rise occurred despite below-average trading volume of 1.41 million shares, indicating limited market conviction. Clarity's market capitalization stands near A$994 million, but the company remains unprofitable with a trailing twelve months (TTM) diluted earnings per share (EPS) of -0.28 AUD and a year-over-year EPS decline of 70.72%. Investors appear hopeful for potential near-term catalysts such as partnering or licensing deals that commonly stimulate mid-cap biotech stocks. The price advance reflects sector sentiment more than fundamental improvement, underscored by the absence of a meaningful price-to-earnings (P/E) ratio due to ongoing losses.

Latest articles

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

21 May 2026
Stellantis announced a €60 billion, five-year plan Thursday, focusing investment on Jeep, Ram, Peugeot, Fiat, and its commercial vehicles. Shares dropped over 5% in early European trading after the announcement. The company aims to launch over 60 new vehicles by 2030 and cut development cycles to 24 months. CEO Antonio Filosa is targeting 25% North American revenue growth and €6 billion in annual cost reductions.
Nike stock climbs but analysts hold back on turnaround calls

Nike stock climbs but analysts hold back on turnaround calls

21 May 2026
Nike shares climbed 3.4% to $44.07 Wednesday as falling oil prices and lower U.S. Treasury yields boosted consumer stocks. Nike reported flat quarterly revenue at $11.3 billion, with direct-to-consumer sales down 4% and net income down 35%. The company plans to launch a Google Gemini-powered shopping feature in June. Nike’s global footwear market share slipped to 22.9% in 2025, while Adidas gained, Reuters said.
Infleqtion shares react to $100 million quantum funding news in Washington

Infleqtion shares react to $100 million quantum funding news in Washington

21 May 2026
Infleqtion shares rose 5.1% premarket Thursday after the U.S. Commerce Department signed a preliminary $100 million funding letter for its neutral-atom quantum computing project, which would also give the government stock in the company. The proposed award, not yet final, is contingent on milestones and approvals. INFQ last traded at $11.18 before the New York open. D-Wave and Rigetti also saw premarket gains.
Gold price hits another record — what GLD and gold stocks are doing before the open
Previous Story

Gold price hits another record — what GLD and gold stocks are doing before the open

Broadcom stock slides after report China told firms to drop VMware, other foreign cyber tools
Next Story

Broadcom stock slides after report China told firms to drop VMware, other foreign cyber tools

Go toTop